Quantum Genesis AI Corp. (QGAI)

OTCMKTS · Delayed Price · Currency is USD
0.1275
-0.0925 (-42.05%)
At close: Jun 26, 2026
Market Cap5.22M -88.3%
Revenue (ttm)n/a
Net Income-4.44M
EPS-0.12
Shares Out 40.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume187,971
Open0.2200
Previous Close0.2200
Day's Range0.0340 - 0.2200
52-Week Range0.0011 - 5.0400
Beta8.08
Analystsn/a
Price Targetn/a
Earnings DateNov 17, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w... [Read more]

Sector Materials
Founded 2015
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol QGAI
Full Company Profile

Financial Performance

Financial Statements